TYP
Click for more information
5.00% 2.1¢ tryptamine therapeutics limited

Ann: September Quarterly Report and Appendix 4C, page-8

  1. Nostrovostro
    4,283 Posts.
    lightbulb Created with Sketch. 13
    clock Created with Sketch.
    28/10/20
    13:21
    Post #: 48454427
    "Disclaimer: Spotee and/or its directors, employees, representatives and associates hold an interest in Exopharm." - A strong indication for the quality of EX1. Just be patient I believe good things will come and if you do really good research you will see why.
    EX1 Price at posting: 37.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch
right-arrow Created with Sketch.
TLG Talga expands Prospectus Offer to $9M, banks $18.5M overall since end of financial year
right-arrow Created with Sketch.
NEWS Results wrap: Wesfarmers, Southern Cross Media, Qantas
right-arrow Created with Sketch.
EBR EBR reaches review milestone for wireless cardiac pacing device
right-arrow Created with Sketch.
EMR Emerald expands underground resource by 105Koz at Cambodian gold mine Okvau
right-arrow Created with Sketch.
NEWS Government spend has to stop or interest rates must rise, property expert
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
2.1¢ 		Change
0.001(5.00%) 		Mkt cap ! $22.87M
Open High Low Value Volume
2.0¢ 2.2¢ 2.0¢ $6.785K 314.2K

Buyers (Bids)

No. Vol. Price($)
4 181927 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 107354 1
View Market Depth
Last trade - 13.20pm 30/08/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.